Savara presents biomarker data from phase 3 trial at ATS conference

May 20, 2026 8:15 AM

Savara Inc. (NASDAQ: SVRA) presented biomarker data from its IMPALA-2 Phase 3 clinical trial at the American Thoracic Society International ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found